Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe human infections and dromedary camels are considered an intermediary host. The dynamics of natural infection in camels are not well understood. Through systematic surveillance in Egypt, nasal, rectal, milk, urine and serum samples were collected from camels between June 2014 and February 2016. Locations included quarantines, markets, abattoirs, free-roaming herds and farmed breeding herds. The overall seroprevalence was 71% and RNA detection rate was 15%. Imported camels had higher seroprevalence (90% vs 61%) and higher RT-PCR detection rates (21% vs 12%) than locally raised camels. Juveniles had lower seroprevalence than adults (37% vs 82%) but similar RT-PCR detection rates (16% vs 15%). An outbreak in a breeding herd, showed that antibodies rapidly wane, that camels become re-infected, and that outbreaks in a herd are sustained for an extended time. Maternal antibodies titers were very low in calves regardless of the antibody titers of the mothers. Our results support the hypothesis that camels are a reservoir for MERS-CoV and that camel trade is an important route of introducing the virus into importing countries. Findings related to waning antibodies and re-infection have implications for camel vaccine development, disease management and zoonotic threat.
Foot and Mouth Disease Virus causes continuously annoying outbreaks and massive animal illnesses. Usually, the potential influence of the disease was due to the emergence of conquered emergent new strains or re-emergence of local strains with major antigenic variations due to the mutation in the genetic strip. Therefore, the proposed work is based on the genetic characterization of the virus by VP1 codon sequencing in the tested samples. Besides, the viral physiological testing using BHK-21 cell lines and the ELISA test for FMDV antigen serotyping. Positive serotype A samples were furtherly analyzed for nucleotide sequencing. The resulting sequences showed that they belonged to the FMD serotype A African topotypes originating from the ancestor prototype SUD/77 with a similarity of 98.48 ± 1.2% with each other. The divergence was 9.3% from the other local isolates from 2020. Additionally, they are closely related to the Egyptian-Damietta type-2016 and the Sudanese-2018 by 96.84 ± 1.01% and 95.84 ± 0.79%, respectively. Moreover, the divergence with the vaccinal strains ranged from 10 to 17%. Ultimately, the analysis of the amino acid showed that the isolates have variation in the most prominent antigenic regionsof of, allocated at residues 35–75, and at the immunogenic determinants of the G-H loop of VP1 (residues 100–146, residues 161–175). Therefore, the current isolates should be included in the vaccine to provide broader immunogenic coverages against serotype A-African topotypes.
The management of children with a pink pulseless hand in severely displaced supracondylar humeral fractures remains controversial regarding immediate exploration of the brachial artery and revascularization during fracture fixation or just closed reduction of the fracture and percutaneous pinning and follow up of limb perfusion.Between 2012 and 2016 we followed 52 children with displaced supracondylar fracture humerus. All patients had absent radial pulse with an otherwise well perfused hand. The radial pulse was returned in all patients, without surgical exploration after closed reduction of the fracture and percutaneous pinning .It takes variable periods from 1week to 2 months . Radial pulse recovery may be due to recanalization of brachial artery or by collaterals. So closed reduction of the fracture, percutaneous pinning and observation is a good option of treatment pediatric supracondylar humeral fractures with a pink pulseless hand without need to do early revascularization procedures.PDF created with pdfFactory Pro trial version www.pdffactory.com
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.